as on November 8, 2025 at 2:29 am IST
Day's Low
Day's High
2.95%
Downside
1.94%
Upside
52 Week's Low
52 Week's High
15.13%
Downside
34.96%
Upside
Check Dynavax Technologies Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.3B
EPS (TTM)
-0.5
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.69%
PE Ratio (TTM)
85.9
Industry PE ratio
-0.8126129032258065
PEG Ratio
0EBITDA
24.2M
Revenue (TTM)
330.5M
Profit Margin
-13.13%
Return On Equity TTM
-7.14%
Track how Dynavax Technologies Corporation P/E has moved over time to understand its valuation trends.
Dynavax Technologies Corporation in the last 5 years
Lowest (-69.66x)
June 30, 2021
Industry (-0.81x)
November 8, 2025
Today (85.90x)
November 8, 2025
Highest (104.30x)
June 30, 2024
Today’s Price to Earnings Ratio: 85.90x
Compare market cap, revenue, PE, and other key metrics of Dynavax Technologies Corporation with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.3B | NA | 85.9 | -13.13% | |
| BUY | $19.3B | NA | 17.02 | 40.65% | |
| BUY | $41.9B | NA | 21.88 | 13.81% | |
| BUY | $15.4B | 58.16% | 36.95 | 15.95% | |
| BUY | $52.7B | -28.96% | 20.13 | 28.21% |
The Dynavax Technologies Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Dynavax Technologies Corporation investment value today
Current value as on today
₹88,468
Returns
Returns from Dynavax Technologies Corporation Stock
Dollar Returns*
₹5,147 (+5.15%)
Based on 12 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Dynavax Technologies Corporation. Average target price of $22.8
Get share price movements and forecasts by analysts on Dynavax Technologies Corporation.
What analysts predicted
52.46%UPSIDE
Target Price
$22.8
Current Price
$10.84
Analyzed by
12 Analysts
Target
$22.80
Dynavax Technologies Corporation target price $22.8, a slight upside of 52.46% compared to current price of $10.84. According to 12 analysts rating.
Search interest for Dynavax Technologies Corporation Stock has increased by 17% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:17% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, DVAX stock has moved up by 7.1%
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -96.09M → 18.72M (in $), with an average increase of 613.3% per quarter
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 68.16M → 95.44M (in $), with an average increase of 28.6% per quarter
Against Peers
![]()
In the last 3 years, United Therapeutics Corporation has given 24.9% return, outperforming this stock by 36.6%
Against Peers
![]()
In the last 1 year, Neurocrine Biosciences Inc. has given 23.1% return, outperforming this stock by 38.6%
| Organisation | Dynavax Technologies Corporation |
| Headquarters | 2100 Powell Street, EmeryVille, CA, United States, 94608 |
| Industry | Health Technology |
| CEO | Mr. Ryan Spencer |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Joseph Metzinger | VP & Chief Accounting Officer |
Mr. Jeff P. Coon | Senior VP & Chief Human Resources Officer |
Ms. Kelly MacDonald CPA | Senior VP & CFO |
Dr. Robert Janssen M.D. | Chief Medical Officer and Senior VP of Clinical Development, Medical & Regulatory Affairs |
Mr. John L. Slebir | Senior VP & General Counsel |
Mr. Paul Cox | VP of Investor Relations & Corporate Communications |
Mr. Donn Casale | Senior VP & Chief Commercial Officer |
Dr. Dong Yu | Senior Vice President of Research |
Mr. Ryan Spencer | CEO & Director |
Mr. David F. Novack | President & COO |
Dynavax Technologies Corporation share price today is $10.84 as on at the close of the market. Dynavax Technologies Corporation share today touched a day high of $11.05 and a low of $10.52.
Dynavax Technologies Corporation share touched a 52 week high of $14.63 on and a 52 week low of $9.2 on . Dynavax Technologies Corporation stock price today i.e. is closed at $10.84,which is 25.91% down from its 52 week high and 17.83% up from its 52 week low.
Dynavax Technologies Corporation market capitalisation is $0.00T as on .
Indian investors can start investing in Dynavax Technologies Corporation (DVAX) shares with as little as ₹88.66 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.60 in Dynavax Technologies Corporation stock (as per the Rupee-Dollar exchange rate as on ).
Based on Dynavax Technologies Corporation share’s latest price of $10.84 as on November 8, 2025 at 2:29 am IST, you will get 0.9225 shares of Dynavax Technologies Corporation. Learn more about
fractional shares .